Completed Access to Information Requests

Follow:

  • RSS
  • Cite
About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA). For additional information, please see the “About Access to Information Requests” webpage.

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Report Type

Organization

Disposition

Year

Month

Found 63414 record(s)

Req # A-2022-000028

Adverse Drug Reactions (ADRs). Report numbers: E2B_04704010, E2B_04718385, 970537, 970543, 971165, 971396, E2B_04773942, E2B_04774155, E2B_04751076, E2B_04763945.

Organization: Health Canada

69 page(s)
June 2022

Req # A-2022-000029

Adverse Drug Reactions (ADRs). Report numbers: 977404, E2B_04787155, E2B_04795026, E2B_04798528, 971605, 972249, 971392, 973210, 973216, E2B_04801281.

Organization: Health Canada

107 page(s)
June 2022

Req # A-2022-000053

Adverse Drug Reaction (ADR) for Duloxetine. Report number: E2B_03524643.

Organization: Health Canada

10 page(s)
June 2022

Req # A-2022-000090

Adverse Drug Reactions (ADRs). Report numbers: E2B_04605581, 000977975, 000919919.

Organization: Health Canada

19 page(s)
June 2022

Req # A-2022-000109

Adverse Drug Reaction (ADR). Report number: E2B_05036607.

Organization: Health Canada

16 page(s)
June 2022

Req # A-2022-000112

Adverse Drug Reactions (ADRs) for METFORMIN HYDROCHLORIDE, FUROSEMIDE, ZOPICLONE. Report numbers: E2B_05023248, E2B_05022807, 000979129.

Organization: Health Canada

77 page(s)
June 2022

Req # A-2022-000134

Adverse Drug Reactions (ADRs). Report numbers: E2B_05047315, E2B_05020536, E2B_05020637, E2B_05041511, E2B_05041459, E2B_05045834, E2B_05046437, E2B_05041471, E2B_05041425, E2B_05040695.

Organization: Health Canada

148 page(s)
June 2022

Req # A-2022-000138

Adverse Drug Reactions (ADRs). Report numbers: E2B_05047027, E2B_05047007, E2B_05047008, E2B_05032714, E2B_05047247, E2B_05032733, E2B_05041001, E2B_05020276, E2B_05047216, E2B_05020281.

Organization: Health Canada

119 page(s)
June 2022

Req # A-2022-000139

Adverse Drug Reactions (ADRs). Report numbers: E2B_05047184, E2B_05041488, E2B_05020333, E2B_05020355, E2B_05020315, E2B_05027342, E2B_05046997, E2B_05046193, E2B_05046064, E2B_05045912.

Organization: Health Canada

94 page(s)
June 2022

Req # A-2022-000142

Adverse Drug Reactions (ADRs). Report numbers: E2B_05047139, E2B_04992027, E2B_05027475, E2B_05041470, E2B_05041401, E2B_05041337, E2B_05020364.

Organization: Health Canada

85 page(s)
June 2022
Date modified: